Does insulin-like growth factor-binding protein 7 alter the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells?
IGFBP7 could be a useful predictor of the response to IFN-based therapy in advanced HCC.
The influence of the swab type on subsequent diagnostic results is often underestimated. Uptake and release of the investigated bacteria vary significantly between different swab types and sampling conditions. For best diagnostic outcome swabs should be chosen according to the examined situation and the swab performance profile.